Intelligence · Clinical Development
Pipeline search results
Programs matching “ischemic stroke” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 60 pipeline programs matching "ischemic stroke" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
16-739
Disc Medicine
Perinatal Arterial Ischemic Stroke (PAIS)
1 trial -
Bu-Yang-Huan-Wu Tang
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ischemic Stroke
1 trial -
CARBOCAINE 20 mg/ml, solution injectable
Pari Pharma GmbH
Ischemic stroke
1 trial -
GEN-100
Lacuna Pharma Pty Ltd
Acute Ischemic Stroke
1 trial -
Human Adipose-Derived Stem Cell Exosomes
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
PURSUIT
AstraZeneca AB
Dyslipidemia Dyslipidemias are alterations to the plasma lipid profile associated often with clinical condition. A common form of dyslipidemia is Hypercholesterolemia due to high level of LDL-cholesterol, which is a major risk factor for Cardiovascular Disease (CVD), such as Ischemic Heart Disease and Ischemic Stroke. CVD is a leading cause of global mortality and a contributor to disability.
1 trial -
Recombinant human tissue kallikrein
DiaMedica Therapeutics
Acute Ischemic Stroke
1 trial -
SODIUM CHLORIDE SOLUTION 0.9%
Lacuna Pharma Pty Ltd
Acute Ischemic Stroke
1 trial -
TAK-755
Takeda
Acute Ischemic Stroke
1 trial -
Tenecteplase
Neuroscience Trials Australia
Ischemic Stroke
1 trial -
22375
Bayer AG
Prevention of ischemic stroke in patients after an acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack in combination with antiplatelet therapy
1 trial -
22665
Bayer AG
Prevention of ischemic stroke in patients post acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack
1 trial -
22806
Bayer AG
atrial fibrillation, transient ischemic attack (TIA), ischemic stroke
1 trial -
Intercerebral implantation of allogenic CD34+ stem cell
Hospital Authority, Hong Kong
Ischemic Stroke
1 trial -
hUCB
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Edaravone dexborneol
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
IIBSP-HOP-2021-01
The George Institute
Acute Ischemic Stroke
1 trial -
Intravenous thrombolysis + edaravone
The First People's Hospital of Lianyungang
Ischemic Stroke
1 trial -
Minocycline
The First People's Hospital of Lianyungang
Ischemic Stroke, Acute
2 trials -
Qizhitongluo Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ischemic Stroke
1 trial -
Rucacuzumab plus standard therapy
The First People's Hospital of Lianyungang
Acute Ischemic Stroke AIS
1 trial -
Xingnaojing injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Xingnaojing injection
The First People's Hospital of Lianyungang
Ischemic Stroke, Acute
1 trial -
Xingnaojing injection
Universal Integrated
Acute Ischemic Stroke
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.